| Course | NS460 Dietary Supplements and Nutraceuticals |
|---|---|
| Unit | Unit 6 |
| Paper type | Interaction review |
| Length | About 880 words, 6 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Nutrition Science |
| Updated | October 2026 |
Free sample paper for NS460 Unit 6
Both Directions for Every Pair: A Unit 6 Interaction Review of Coenzyme Q10 With Atorvastatin, Warfarin and Lisinopril
[Student Name]
Purdue University Global
NS460: Dietary Supplements and Nutraceuticals
Unit 6 Interaction Review
[Instructor Name]
[Date]
The client and her medicine list are composite; the trials and meta-analyses cited are real, and the review is not a substitute for a pharmacist's check.
The Client
Marlene, 67, retired after thirty years as a court stenographer. She takes atorvastatin 40 mg daily for high cholesterol, warfarin for atrial fibrillation with her dose adjusted to her INR, and lisinopril 20 mg for high blood pressure. She developed aching thighs after starting the statin, and a friend told her to take coenzyme Q10, 200 mg a day. She bought a softgel and asked her nutrition counselor whether it was safe before starting.
Method
Each of her three medicines was paired with CoQ10, and each pairing was checked in two directions: what the drug does to CoQ10 or to the reason for taking it, and what CoQ10 does to the drug or its effect. Evidence was graded as a controlled trial, a meta-analysis, or case reports and mechanism.
Pair 1: Atorvastatin and CoQ10
Drug on supplement. Statins block an enzyme early in the pathway the body uses to make both cholesterol and CoQ10, so blood CoQ10 levels fall during statin therapy. This is the reason Marlene's friend suggested it.
Supplement on drug. There is no good evidence that CoQ10 reduces the cholesterol-lowering effect of statins.
Does it help the muscle aches? The evidence is mixed. Pooling a dozen randomized trials and 575 patients, one meta-analysis reported that CoQ10 reduced statin-associated muscle pain compared with placebo (Qu et al., 2018). But a well-designed trial that first confirmed statin-related muscle symptoms found no benefit; CoQ10 raised blood levels fourfold, yet pain increased equally in both groups (Taylor et al., 2015). When retested without knowing whether they were taking the statin, just 36 percent of those patients developed muscle pain again.
Rating: no harmful interaction; benefit uncertain.
Pair 2: Warfarin and CoQ10
Drug on supplement. Warfarin does not appear to affect CoQ10 levels.
Supplement on drug. This is the pairing that matters. CoQ10 is chemically similar to vitamin K, and case reports have described lower INR values, meaning reduced warfarin effect, after people started CoQ10. In a small placebo-controlled crossover trial of patients on stable warfarin, 100 mg of CoQ10 daily for four weeks did not change INR or warfarin dose (Engelsen et al., 2002). That trial was small, used a lower dose than Marlene plans, and lasted only four weeks.
The warfarin pairing is the one that needs action, not because the trial evidence shows harm, but because a small, short trial at half Marlene's dose cannot rule out the effect the case reports describe.
Rating: possible interaction; monitor.
Pair 3: Lisinopril and CoQ10
Drug on supplement. No known effect.
Supplement on drug. A meta-analysis of 12 small trials, most of them open label, reported that CoQ10 lowered blood pressure, by about 17 mm Hg systolic in the three randomized trials (Rosenfeldt et al., 2007). The quality of those trials was low, and later reviews have been less positive. Combined with lisinopril, any blood pressure effect could add to the drug's.
Rating: possible additive effect; low concern at usual doses, but worth noting.
What This Means for Marlene's Muscle Aches
The muscle aches are the reason Marlene wants CoQ10, so they deserve attention apart from the interactions. Aching thighs after starting a statin can come from the drug, but they can also come from other causes common at her age, such as arthritis, low vitamin D or a thyroid problem, and the blinded retesting in the trial above suggests many people blame the statin for pain that has another source. Her prescriber can check for those causes, measure a muscle enzyme if the pain is severe, and consider a lower dose, a different statin or a different schedule. Each of those options has stronger evidence than CoQ10. If she still wants to try the supplement after that conversation, a trial of a few weeks with her INR watched closely is a reasonable compromise.
Summary Table, Written Out
1. Atorvastatin with CoQ10: no harmful interaction; effect on muscle aches uncertain.
2. Warfarin with CoQ10: possible reduced warfarin effect; INR should be checked within one to two weeks after starting or stopping.
3. Lisinopril with CoQ10: possible small additional lowering of blood pressure; home readings advised.
Recommendations
Marlene should tell her prescriber and the clinic managing her warfarin before starting CoQ10, so her INR can be checked sooner than usual. She should not stop or start CoQ10 without telling them, since either change could shift her INR. She should check her blood pressure at home for the first few weeks and report any dizziness. She should also ask her prescriber about her muscle aches directly, since options such as changing the statin or the dose have better evidence than CoQ10.
Limits of This Review
This review relies on published studies and does not replace a pharmacist's interaction check. Supplement products vary in content, and Marlene's softgel may contain more or less than its label states. The case reports on warfarin cannot show how often the interaction occurs.
References
Engelsen, J., Nielsen, J. D., & Winther, K. (2002). Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients: A randomised, double blind, placebo-crossover trial. Thrombosis and Haemostasis, 87(6), 1075-1076. https://doi.org/10.1055/s-0037-1613135
Qu, H., Guo, M., Chai, H., Wang, W., Gao, Z., & Shi, D. (2018). Effects of coenzyme Q10 on statin-induced myopathy: An updated meta-analysis of randomized controlled trials. Journal of the American Heart Association, 7(19), e009835. https://doi.org/10.1161/JAHA.118.009835
Rosenfeldt, F. L., Haas, S. J., Krum, H., Hadj, A., Ng, K., Leong, J.-Y., & Watts, G. F. (2007). Coenzyme Q10 in the treatment of hypertension: A meta-analysis of the clinical trials. Journal of Human Hypertension, 21(4), 297-306. https://doi.org/10.1038/sj.jhh.1002138
Taylor, B. A., Lorson, L., White, C. M., & Thompson, P. D. (2015). A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis, 238(2), 329-335. https://doi.org/10.1016/j.atherosclerosis.2014.12.016
NS460 Unit 6 instructions, in plain terms
The sixth NS460 unit asks students to review possible interactions between a supplement and a client's medicines. Prompts usually expect each pairing to be examined, the evidence graded and practical recommendations given. Describe the client and every medicine with its purpose. For each drug and supplement pair, ask two questions: what the drug does to the supplement, and what the supplement does to the drug or its effect. Classify the evidence for each, from trials to case reports and mechanism. Rate each pairing and say what monitoring it needs. Address the reason the client wants the supplement, since better options may exist. Give recommendations within your scope, directing medication decisions to the prescriber. Note the limits of your review. Three to five pages is common, with each pair under its own heading.
How the NS 460 Unit 6 example is put together
The sample introduces the client, her three medicines and her reason for wanting CoQ10. A method section explains the two-direction check and the evidence grades. The statin pair covers CoQ10 depletion, the meta-analysis favoring benefit for muscle pain and the confirmed-myopathy trial finding none. The warfarin pair explains the vitamin K similarity, the case reports and the small crossover trial, and a highlighted sentence explains why caution remains. The lisinopril pair reports the blood pressure meta-analysis and its low quality. A section on the muscle aches points to causes and options with stronger evidence. A written summary table, recommendations and limits close the review.
NS460 Unit 6 rubric: what earns full points
Interaction reviews are usually judged on completeness, accuracy, appropriate grading of evidence and safe, in-scope recommendations. A significant share of points depends on checking every pair in both directions rather than only the obvious interaction. Instructors reward accurate reporting of trial details and honest grading of case reports. Identifying the pairing that needs action, and explaining why, shows clinical judgment. Recommendations should direct medication decisions to prescribers and include monitoring. Addressing the reason for taking the supplement adds value. Acknowledging limits, including product variability and the role of a pharmacist, demonstrates appropriate scope. Clear structure and APA 7 references complete the grade.
NS460 Unit 6 help: mistakes that cost points
A common interaction review mistake is checking only whether the supplement affects the drug, not the reverse. Another is treating case reports as proof or ignoring them entirely. Writers often miss interactions with drugs other than the one that prompted the question. Recommendations sometimes tell the client to change doses, which is outside nutrition scope. The client's reason for wanting the supplement is ignored, though better options may exist. Product quality is overlooked. If you have a client's medicine list and a supplement to check but are unsure how to organize the evidence, a writer can help you set up each pair and grade what is known.
Get an NS460 Unit 6 example written to your instructions
Every prescription and product in the Unit 6 case matters, so paste the list whole, adding the rubric and any assigned database. Each pairing is checked in both directions with evidence type labeled cell by cell, and findings go to whoever manages each drug. A first sample is free and returns within 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NS460 papers and BS in Nutrition Science samples
- NS460 Unit 1: Biotin Gummy Discussion Post
- NS460 Unit 2: Supplement Regulatory Brief
- NS460 Unit 3: Elderberry Syrup Label Analysis
- NS460 Unit 4: Glucosamine Supplement Monograph
- NS460 Unit 5: Berberine Seminar Reflection
- NS460 Unit 7: Botanical Case Study
- NS460 Unit 8: Consumer Handout
- NS460 Unit 9: Systematic Review Summary
- NS460 Unit 10: Final Product Review
- NS455 Unit 6: Glucose Monitor Fact Sheet
- NS420 Unit 6: Goal-Setting Worksheet
- NS410 Unit 6: Menu Design Seminar Reflection
- NS325 Unit 6: Four-Stage Household Reflection
NS460 Unit 6 questions, answered
What does checking in both directions mean in practice?
Asking two separate questions about every pair: does the drug change the supplement's levels or effects, and does the supplement change the drug's? They often have different answers with different evidence behind them. A two-column layout makes the distinction visible, and graders in this unit commonly look for that separation before they read anything else.
Should a case report count as evidence?
Yes, as evidence of a possible signal, reported as such. Case reports cannot show how often something happens or prove cause, but they are often the first warning of an interaction, and several consistent reports justify caution. Label them clearly and set them beside any controlled data, especially where the two disagree, so the reader sees why monitoring is still warranted.
Can I recommend stopping the supplement if the risk looks high?
The review can state that a pairing needs the prescriber's attention before the product is continued, which is within scope. Telling the client to stop, start or change a dose is not, because the prescriber may prefer monitoring to removal. Name the concern, the evidence and the person who decides, and let the review end there.
Where can I find a free NS460 Unit 6 sample paper?
This page holds a complete Unit 6 interaction review of coenzyme Q10 with atorvastatin, warfarin and lisinopril, checking each pair in both directions and ending with in-scope recommendations.
Does CoQ10 interact with warfarin, according to the NS460 Unit 6 sample?
Possibly. CoQ10 resembles vitamin K, and case reports describe lower INR values after starting it. A small trial found no effect at 100 mg for four weeks, so the review advises an earlier INR check rather than assuming safety.